Related Experiment Video
Updated: May 16, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the
Ludovic Samalin1, Sebastien Guillaume, Philippe Courtet
1Department of Adult Psychiatry B, CHU Clermont-Ferrand, 58 rue Montalembert, 63000 Clermont-Ferrand, France. lsamalin@chu-clermontferrand.fr
Objective:
Numerous guidelines for bipolar disorder have been published. The aim of this article is to underline the main differences between consensus-based guidelines (CBG) and evidence-based guidelines (EBG) currently available for the management of bipolar disorder.
Methods:
A literature search for guidelines published since 2006 was performed. A qualitative analysis was then conducted to compare the methodologies and the guidelines contents.
Results:
Comparison between CBG and EBG found more similarities than differences. However, discordances were found in the first-line choice of treatment (monotherapy or combination, use of lamotrigine or lithium in bipolar depression), time to reassessment and duration of maintenance treatment, introduction as from the acute phase a regimen compatible with long-term use and pharmacotherapy during pregnancy.
Conclusions:
The choice of policy, whatever the methodology used, is up to the authors and can, therefore, depend on their interpretation of the available scientific evidence. Combining both methodologies (CBG and EBG) enables us to meet the complete definition of evidence-based medicine.
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Drug Therapy
Antianxiety Medications
Bipolar Disorder
Antidepressant Drugs: MAOIs and Other Agents